| P2093 | author name string | Perry M Elliott | |
| | Saidi A Mohiddin | |
| P2860 | cites work | ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene | Q24315109 |
| | Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy | Q24594051 |
| | A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy | Q24601469 |
| | Cardiovascular magnetic resonance in myocarditis: A JACC White Paper | Q24654343 |
| | Rare variant mutations identified in pediatric patients with dilated cardiomyopathy | Q28235313 |
| | Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype | Q28236991 |
| | Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study | Q28238424 |
| | Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study | Q28246153 |
| | Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis | Q28268187 |
| | Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy | Q28275501 |
| | Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes | Q28279508 |
| | Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice | Q28279991 |
| | Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy | Q28282054 |
| | Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology | Q30474368 |
| | A global in vivo Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function. | Q30494112 |
| | Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers | Q33158326 |
| | Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia | Q33159168 |
| | Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events. | Q33159927 |
| | Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria | Q33764619 |
| | Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes | Q33787873 |
| | Common susceptibility variants examined for association with dilated cardiomyopathy. | Q33836110 |
| | Comparison of the Illumina Genome Analyzer and Roche 454 GS FLX for resequencing of hypertrophic cardiomyopathy-associated genes. | Q33908627 |
| | Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. | Q33978864 |
| | A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. | Q34003962 |
| | Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy | Q34015228 |
| | De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy | Q34137061 |
| | The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy | Q34327150 |
| | Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy | Q34629550 |
| | Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations | Q34916619 |
| | Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy | Q34992640 |
| | Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy | Q35102865 |
| | The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy | Q57901799 |
| | Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy | Q57901803 |
| | Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy | Q57901826 |
| | Prevalence of Desmosomal Protein Gene Mutations in Patients With Dilated Cardiomyopathy | Q57901844 |
| | Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy | Q61772667 |
| | Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. | Q64934138 |
| | Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy | Q82327642 |
| | Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients | Q83312124 |
| | Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries | Q83879208 |
| | Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks | Q84119314 |
| | Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin | Q84357884 |
| | Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy | Q84517546 |
| | Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy | Q84626234 |
| | Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy | Q84713334 |
| | Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy | Q84775782 |
| | Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes | Q35197101 |
| | The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications | Q35685801 |
| | Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction | Q35771965 |
| | Mechanisms and management of the heart in myotonic dystrophy | Q36069666 |
| | Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy | Q36761955 |
| | Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy | Q37435693 |
| | Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy | Q37695397 |
| | DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model | Q37714183 |
| | Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q37798617 |
| | Use and interpretation of genetic tests in cardiovascular genetics | Q37799459 |
| | Trimetazidine: a meta-analysis of randomised controlled trials in heart failure | Q37816716 |
| | Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist | Q37962903 |
| | Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. | Q38482810 |
| | Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. | Q38484008 |
| | Evaluation of second-generation sequencing of 19 dilated cardiomyopathy genes for clinical applications | Q42398314 |
| | Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. | Q42870189 |
| | Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution | Q43120634 |
| | Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment | Q43144686 |
| | Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience | Q43250122 |
| | Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy | Q43766778 |
| | Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk | Q44147600 |
| | Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy | Q44151643 |
| | Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis | Q44306392 |
| | Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony | Q44314535 |
| | Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: what statistics cannot tell you. | Q45072736 |
| | Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study. | Q45989315 |
| | Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. | Q51102867 |
| | Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy | Q51149024 |
| | Primary prevention of sudden death in patients with lamin A/C gene mutations. | Q51289514 |
| | Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. | Q51419355 |
| | Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study. | Q51533470 |
| | Relation of replacement fibrosis to left ventricular diastolic function in patients with dilated cardiomyopathy. | Q51600855 |
| | Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. | Q53241319 |
| | Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. | Q53251747 |
| | Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy. | Q53310052 |
| | Quantitative trait locus analysis, pathway analysis, and consomic mapping show genetic variants of Tnni3k, Fpgt, or H28 control susceptibility to viral myocarditis. | Q54375844 |
| | Long-term benefits of pacing in obstructive hypertrophic cardiomyopathy. | Q54478600 |
| | Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. | Q54618727 |
| | Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction | Q56986761 |
| | 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy De | Q57312501 |
| | The Importance of Genetic Counseling, DNA Diagnostics, and Cardiologic Family Screening in Left Ventricular Noncompaction Cardiomyopathy | Q57364826 |
| | A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy | Q57574269 |
| | Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis | Q57744016 |
| | Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations | Q57841015 |
| P433 | issue | 4 | |
| P304 | page(s) | 235-240 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : časopis Društva za medicinsku informatiku BiH | Q26842876 |
| P1476 | title | Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology | |
| P478 | volume | 19 | |